2. Tests available for detecting syphilis
Direct identification of
T.pallidum
Direct microscopic
identification of T.pallidum by
dark field microscopy
Direct antigen detection tests
Nucleoside amplification
techniques (PCR)
Serological tests to
detect IgG/Igm
antibodies
Non Treponemal tests (for
determining the disease
activity)
Treponemal tests (for disease
confirmation)
Detection of Treponemal IgM
antibodies ( to detect early
infection)
3. Dark Field Microscopy
This method is traditionally used to demonstrate T.pallidum
in the exudate from mucocutaneous lesions in early acquired
and early congenital syphilis
One of the most specific and easiest method for diagnosis of
infectious syphilis when lesions are present
5. Procedure
Clean the lesion with a saline soaked gauze and squeeze it
between the index finger and the thumb to produce a serous
exudate.( avoid contamination with blood)
The exudate is then transferred onto a glass slide by directly
pressing it on the lesion
Normal saline can be added to the exudate to make the
material homogenous
The specimen should immediately be examined as delay in
examination reduces the motility of the treponemes
6. Results
T.pallidum in dark field microscopy is identified by its typical
morphology and characteristic movements
T.pallidum is differentiated from the other treponemes by
the tightness of spirals and characteristic cork screw
movements
T pallidum
Other non pathogenic treponemes
Has 6-14 regularly wounded coils
Irregularly wounded coils
And may be longer & thicker
Shows a slow, deliberate forward &
backward movement, rotating on its long
axis, soft bending and twisting from side to
side
Lack a characteristic mobility
9. Advantages
Easy to do
Most specific method to
confirm the diagnosis in early
syphilis
disadvantages
Time consuming
Needs operator expertise
needs well maintained
specialist equipment
Cannot differentiate T.pallidum
from other pathogenic
treponemes
Not recommended for oral
cavity lesions
10. Direct fluorescent antibody-T.pallidum
(DFA-TP)
It is a practical alternative to dark field examination
Advantages
More sensitive and specific
than dark field microscopy
Samples from oral mucosa
can also be examined
Slides need not be examined
immediately
Disadvantages
This test cannot differentiate
T.pallidum subsp pallidum
from other sub species of
T.pallidum
11. Method
The specimen collection is same as that of dark field
microscopy
The slide is air dried and fixed with either acetone for 10 min
or 100% methanol for 10 sec
The smear is stained with fluorescein- labeled anti T. pallidum
globulin and examined under the fluorescent microscope
12. Polymerase chain Reaction
Is increasingly becoming the investigation of choice for
identifying T.pallidum from the early lesions of syphilis
A number of well-preserved DNA sequences have been
identified that are specific for T.pallidum and do not appear
to be found in other treponemes
Assays based on these primers have been shown to be
sensitive and specific in the diagnosis of early syphilis
13. SEROLOGICAL TESTS
Useful in the latent stage of the disease as treponemes are not readily
sustainable in culture and lesions are usually absent
An ideal serological test
1.
should have high specificity & sensitivity
2.
should be suitable for treatment monitoring
3.
should give a negative result on successful therapy to give a clear cut
diagnosis of reinfection
However by using the different but complementary characteristics of
various specific and non specific treponemal tests, a diagnosis of syphilis
and a serological assessment of disease activity, treatment response and
reinfection can be made
14. Principle:
• T.pallidum infection produces antibodies to more than 20 different
polypeptide antigens.
• The antibodies are of two types:
1. Non specific antibodies (reagins): directed against lipoidal antigen of
T.pallidum as well as mitochondrial & nuclear membranes of human
cells
2. Specific anti-treponemal antibodies: directed against T.pallidum
• Specific anti T.pallidum IgM antibodies develop during the second
week of infection
• IgG antibody response begins around the fourth week after infection
and usually persists
• Treatment causes generalized loss of antibodies. However, IgG
antibodies may persist at a low detectable level
15.
16. Non Treponemal Tests
All these non treponemal tests measure anti lipoidal IgM and IgG
antibodies
These tests are used for initial screening and for follow up after
treatment
They can be performed as a:
1.
Qualitative test ( to check for presence or absence of antibodies)
2.
Quantitative test (to check the amount of antibodies present in
the serum)
Except for VDRL & RPR tests, most lipoidal antigen tests are not
used
17. VDRL
Venereal Disease Research Laboratory (VDRL) Test is a slide
flocculation test employed in the diagnosis of syphilis.
Since the antigen used in this test is cardiolipin, which is a
lipoidal extracted from beef heart, it is not a specific test.
The antibodies reacting with cardiolipin antibodies have been
traditionally (but incorrectly) termed “regain”.
17
18. VDRL- Principle
Patients suffering from syphilis produce antibodies that
react with cardiolipin antigen in a slide flocculation
test, which are read using a microscope. It is not known if the
antibodies that react with cardiolipin are produced against
some lipid component of Treponema pallidum or as a result
of tissue injury following infection
19. VDRL- Test Requirements
Patient’s serum, water bath, freshly prepared cardiolipin antigen, VDRL
slide, mechanical rotator, pipettes, hypodermic syringe with unbeveled
needle and microscope. Known reactive and non-reactive serum controls
are also required.
VDRL antigen: The cardiolipin antigen is an alcoholic solution composed of
0.03% cardiolipin, 0.21% lecithin and 0.9% cholesterol. The cardiolipin
antigen must be freshly constituted each day of test. The working antigen
is a buffered saline suspension of cardiolipin.
VDRL slide: This is a glass slide measuring 2 X 3 inch with 12 concave
depressions, each measuring 16 mm in diameter and 1.75 mm deep.
20.
21. procedure
Patients’ serum is inactivated by heating at 560c for 30
minutes in a water bath to remove non-specific inhibitors
(such as complement). The test can be performed both
qualitatively and quantitatively. Those tests that are reactive
by qualitative test are subjected to quantitative test to
determine the antibody titres.
22. Qualitative test:
1. 0.05 ml of inactivated serum is taken into one well.
2. 1/60th ml (or 1 drop from 18 gauge needle) of
the cardiolipin antigen is then added with the help of a syringe
(unbeveled) to the well and rotated at 180 rpm for 4 minutes.
3. Every test must be accompanied with known reactive and nonreactive controls.
4. The slide is then viewed under low power objective of a
microscope for flocculation. The reactive and non-reactive
controls are looked first to verify the quality of the antigen.
Depending on the size the results are graded as weakly reactive
(W) or reactive (R).
5.
Reactive samples are then subjected to quantitative test.
23. QUANTITATIVE TEST:
This is performed to determine the antibody titers
1. The serum is doubly diluted in saline from 1 in 2 to 1:256 or more
2. 0.05 ml of each dilution is taken in the well and 1/60 ml of
antigen is added to each dilution and rotated in a rotator.
1. The results are then checked under the microscope
2. The highest dilution showing flocculation is considered as
reactive titre.
3. If the clinical findings are strongly suggestive of syphilis, a
quantitative test may be directly performed on the serum
specimen.
24.
25. VDRL for CSF
VDRL test may also be performed on CSF samples in the
diagnosis of neurosyphilis
Quantitative VDRL is the test of choice on CSF specimens.
However, there are some variations in this test. The antigen
is diluted in equal volumes with 10% saline, CSF must not be
heated (or inactivated), the volume of antigen solution taken
is 0.01 ml (or 1 drop from 21 gauge needle) and rotation time
is 8 minutes.
Rest of the procedure remains same
26. Reporting of the results
Results of the test are reported as:
1.
REACTIVE: past/ present infection with a pathogenic
T.pallidum, which is either treated or untreated (or) a false
positive reaction
2.
NON REACTIVE: no current infection (or) an effectively
treated infection , but it does not rule out syphilis which can
be in its incubation period
3.
WEAKLY REACTIVE :
27.
28. A four fold rise in titer infection
reinfection
treatment failure
A four fold decrease in titer
effective therapy
When a non treponemal test shows a persistent reactivity with no
signs of decline in titer after 6 months of adequate therapy (or)
fails to show a four fold decrease of an initial high titer within 1
year , it is considered as SERORESISTANCE ( SEROFAST)
29. PROZONE PHENOMENON :
•
Undiluted serum specimens having a high quantity of reagin
antibodies occasionally will give a false negative reaction , but
on further dilutions, it becomes positive
• Incidence of prozone phenomenon in general population has
been observed to be low (0.4%)
• It may attain clinical significance in cases of certain groups of
patients
1. Patients on continuous immunosuppressive therapy
2. HIV seropositive patients
30. False positive reactions
1.
Technical false positive reaction
2.
Variation in the normal :
In some normal individuals, there may be excess
production of reagin antibodies
1.
Biological false positive reaction:
polyclonal antiphospholipid antibodies produced against
lipoidal antigens present in normal tissue and in conditions that
destroy cell nuclei are responsible for this reactions
31. Types of biological false positive reactions
Transient acute reaction
Chronic reaction
Lasts less than 6 months
Lasts more than 6 months
Due to various associated
can be idiopathic or due to
infections, narcotic
abuse, immunization
procedures and pregnancy
leprosy, old age, autoimmune
& other connective tissue
disorders, malignancy etc
32. Variants of VDRL test
Unheated serum reagin (USR) test
Rapid plasma reagin (RPR) test
Reagin screen test (RST)
Automated reagin test (ART)
Toluidine red unheated serum test (TRUST)
34. Treponemal Tests
In these tests, entire T.pallidum or its fragments are used as
the antigen to detect antibodies directed against treponemal
cellular components
These tests are used for confirmation of the disease activity
Treponemal tests become reactive before non treponemal
tests but unlike non treponemal tests they remain positive
for many years even after adequate therapy
36. Fluorescent Treponemal Antibody
Absorption (FTA-Abs) test
It is an indirect immunofluorescence antibody test
• Serum for testing is diluted in sorbent
(containing extract of Reiter treponemal
culture) to absorb the non specific antibodies
• Serum is placed on a microscopic slide to which
the antigen ( a suspension of T.pallidum
organism ) is fixed
• Conjugated fluorescein labeled antihuman
globulin is added
37. The intensity of fluorescence is reported as REACTIVE, BORDERLINE, NON
REACTIVE.
False positives and negatives may occur
It is the most sensitive serological test in early stages of syphilis at present
ADVANTAGES
1. High specificity &
sensitivity
2. Can detect recent
infection 1-2 weeks
before other assays
DISADVANTAGES
1. Expensive
2. Time consuming
3. Reading the test is
tiresome
4. Well trained
personnel is
required
38.
39. Fluorescent Treponemal Antibody Absorption
double staining (FTA-Abs-DS) test
The fluorescent treponemal antibody absorption double staining (FTA ABS
DS) test is an indirect fluorescent antibody technique used as a
confirmatory test for syphilis.
the patient's serum, which has been diluted 1:5 in sorbent (an extract from
cultures of Treponema phagedenis, Reiter treponeme), is layered on a
microscope slide to which T. pallidum subspecies pallidum has been fixed.
Class - specific tetramethylrhodamine isothiocyanate (TMRITC) –labeled
antihuman immunoglobulin G (IgG) is then added; this reagent combines
with the patient's antibodies which are adhering to T. pallidum and results
in a visible test reaction (fluorescing treponemes) when examined by
fluorescence microscopy with the rhodamine filter in place
Finally, a counterstain, fluorescein isothiocyanate (FITC)-labeled anti-
treponemal globulin, is added to locate T. pallidum when the slide is
examined with the FITC filter.
40. Treponema pallidum Haemagglutination
Assay (TPHA)
A qualitative haemagglutination test using tanned formalinised sheep
RBC’s as the carrier for T.pallidum antigen (sensitized cells)
Patients serum is diluted in absorbing diluent which contains:
1.
Sonicated sheep & bovine red cell stroma
2.
Normal rabbit testicular extract
3.
Reiter treponemal sonicate
4.
Normal rabbit serum
5.
Stabilizers
Serum is tested with both sensitised and non sensitised RBC’s
Preliminary results are available in 3-4 hrs, final results in 18 hrs
41. Reporting
REACTIVE : if agglutination occur in a dilution of 1:80 or more
Reactivity Is positive around 4th-5th week of infection
False positive may be due to heteroagglutination , group
specific antibodies
Advantages
1. Less expensive
2. Basic equipment
3. Simply trained staff
Disadvantages
1. less sensitive
in primary
syphilis
42. Variations of TPHA
Microhemagglutination assay with T.pallidum antigen (MHA-
TP)
Automated microhemagglutination assay with T.pallidum
antigen (AMHA-TP)
Haemagglutination treponemal test for syphilis (HATTS)
Finger prick MHA-TP
43. Treponemal Enzyme Immunoassay(EIA)
In this test, serum is added to microwells coated with a treponemal
antigen
An enzyme labeled anti human immunoglobulin conjugate &
enzyme substrate are added to detect antigen-antobody reaction
after incubation
Recent studies suggest that EIA used as a single test is an
appropriate alternative to the combined VDRL/RPR and TPHA test
s
It has the advantages of higher specificity than FTA-Abs and
automated or semi automated processing and objective reading of
results
44. Guidelines for serological screening
If a patient is suspected to have syphilis
EIA test
Perform a
combined
VDRL &
TPHA tests
If REACTIVE
Confirmation of
diagnosis by a
treponemal test of
different type
45. Lab diagnosis of syphilis at various stages
Primary syphilis:
•
A presumptive diagnosis of syphilis can be made based on the presence of
chancre and a proceeding history of sexual contact within the last 3
months
•
During this period; dark field microscopy or PCR or DFA-TP can be used to
confirm the diagnosis
•
Humoral antibody response can be detected by treponemal or non
treponemal tests 1-4 weeks after the chancre has formed
•
Sensitivities of various tests during this stage :
1.
VDRL/RPR – 70-90%
2.
TPPA – 94%
3.
Combined IgG/M assays – 96%
46. Secondary syphilis:
• All serological tests are positive in this stage and sensitivity of all tests
approaches 100%
• Treponemes can be identified in lesions by dark field microscopy or PCR
Presumptive
diagnosis
Presence of a
typical rash
Reactive non treponemal test with a titre
greater than 1:8
(without any past history of syphilis)
Reactive non treponemal test with a
four fold rise in titer ( if past history
of syphilis is present)
47. If the titre is less
than 1:8
Repeat the test
Perform a
treponemal
test
If both tests are positive
Confirmation of
diagnosis
48. Latent syphilis:
• As the lesions are not present in this stage, definitive diagnosis for
treponemes can be done
• All serological tests are reactive in early latency
• However the reactivity to non treponemal tests decreases with
increased duration of latency ( approximately 30% of patients with
latent syphilis are VDRL/RPR non reactive)
• Sensitivity of treponemal tests in latent syphilis varies from 97- 100%
• Most of patients with latent syphilis are diagnosed presumptively on
the basis of reactive syphilis serology during screening
49. Diagnosis of Neurosyphilis
CSF examination is done in:
1.
Patients with neurosyphilis
2.
In patients with syphilis of more than 2 years duration to exclude
asymptomatic neurosyphilis
3.
Before retreatment of of patients who have had relapses after any form
of treatment
4.
As a follow up procedure for patients who have been treated for
neurosyphilis
5.
As a baseline measure in all patients with syphilis for whom non-penicillin
regimens are prescribed
6.
In all infants suspected of prenatal syphilis
50. CSF sample is taken and a cell count is made
It is further checked for protein abnormalities and subjected to
VDRL test
Diagnosis of neurosyphilis is indicated by increased cell count (> 10
lymphocytes per mm3 of CSF) , increased proteins (> 40 mg% in the
CSF) and a REACTIVE VDRL test
Serum VDRL test is reactive in about two thirds of the cases
52. Diagnosis of Syphilis in Pregnancy
All women should be screened serologically for syphilis during the early
stages of pregnancy
Antepartum screening by nontreponemal antibody testing is
typical, but in some settings, treponemal antibody testing is being
used.
For patients at high risk, serologic testing should be performed twice
during the third trimester, at 28 to 32 weeks’ gestation and at delivery
Expectant mothers should be treated when non-treponemal &
treponemal tests are reactive if on thorough evaluation the cause of a
possible false positive result cannot be ensured
Post natal screening for pre natal syphilis in infants born to high risk
mothers at 4-8 weeks of age is appropriate
53.
54. Diagnosis of Syphilis in HIV
Unusual serologic responses have been observed among HIV-infected
persons who have syphilis
The majority of reports have involved serologic titers that were higher than
expected, but false-negative serologic test results and delayed appearance
of seroreactivity also have been reported
majority of specialists believe that both treponemal and nontreponemal
serologic tests for syphilis can be interpreted in the usual manner for the
majority of patients who are coinfected with T. pallidum and HIV.
When clinical findings are suggestive of syphilis but serologic tests are
nonreactive or their interpretation is unclear, alternative tests (e.g., biopsy
of a lesion, dark field examination, or DFA staining of lesion material)
might be useful for diagnosis
Neurosyphilis should be considered in the differential diagnosis of
neurologic disease in HIV-infected persons.